Key regions: Brazil, India, Australia, United States, United Kingdom
Antiviral drugs have been in high demand globally due to the ongoing COVID-19 pandemic. Vietnam is no exception to this trend, with the Antiviral Drugs market in the country experiencing significant growth in recent years.
Customer preferences: Vietnamese customers have shown a preference for antiviral drugs that are affordable, effective, and easily accessible. Due to the high cost of healthcare in Vietnam, customers tend to opt for cheaper alternatives to branded drugs. Additionally, customers are increasingly turning to online pharmacies to purchase antiviral drugs, as it offers more convenience and accessibility.
Trends in the market: The Antiviral Drugs market in Vietnam has been growing at a steady pace in recent years. The COVID-19 pandemic has further accelerated this growth, with an increasing number of people seeking antiviral drugs as a preventive measure. Additionally, the government's efforts to improve healthcare infrastructure and expand access to healthcare services have contributed to the growth of the antiviral drugs market in the country.
Local special circumstances: Vietnam has a rapidly growing middle class, which has led to an increase in demand for healthcare services, including antiviral drugs. Additionally, the country has a large population of young people who are more susceptible to viral infections. The government has also been proactive in implementing measures to prevent the spread of viral infections, which has further contributed to the growth of the antiviral drugs market.
Underlying macroeconomic factors: Vietnam's economy has been growing at a steady pace in recent years, with a focus on industrialization and modernization. This has led to an increase in disposable income and a growing middle class, which has contributed to the growth of the antiviral drugs market. Additionally, the government's efforts to improve healthcare infrastructure and expand access to healthcare services have also contributed to the growth of the market. The ongoing COVID-19 pandemic has further accelerated the growth of the market, with an increasing number of people seeking antiviral drugs as a preventive measure.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
